During the past decade, Gadolin Research, LLC conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gadolin Research, LLC" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored, "Arena Pharmaceuticals" with 1 trials sponsored and "Astellas Pharma Global Development, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gadolin Research, LLC" #1 collaborator was "AbCellera Biologics Inc." with 1 trials as a collaborator, "Clinical Research Management, Inc." with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials as a collaborator and "Vir Biotechnology, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Gadolin Research, LLC" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (2 trials), "Respiratory Tract Infection" (2 trials), "ADHD" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Gadolin Research, LLC" in a lesser frequency.

Most popular intervention types in "Gadolin Research, LLC" are "Drug" (12 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Donanemab" (2 trials), "400mg SPN-812" (1 trials), "600mg SPN-812" (1 trials) and "Bamlanivimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gadolin Research, LLC" are 10 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Gadolin Research, LLC". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Gadolin Research, LLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Gadolin Research, LLC, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".